Oruka Therapeutics, Inc. ORKA Effective Income Tax Rate Reconciliation Tax Credits Research
Effective Income Tax Rate Reconciliation Tax Credits Research at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch.
The official record: Oruka Therapeutics, Inc.’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s effective income tax rate reconciliation tax credits research.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s effective income tax rate reconciliation tax credits research?
- Oruka Therapeutics, Inc. (ORKA) reported effective income tax rate reconciliation tax credits research of -2% in Q4 2025.
- What does effective income tax rate reconciliation tax credits research mean?
- This metric measures the percentage point impact of research and development tax credits on the company's effective tax rate compared to the federal statutory rate. It quantifies the relative significance of R&D tax incentives in optimizing the company's overall tax position.